Xpert® Hemorrhagic Fever Panel
Multiplex Nucleic Acid Detection System For Biothreat Agents. 510(k) K262971, from Cepheid (Sunnyvale, CA). Product code QVR, class 2.
As of Nov 19, 2026, K262971 is an FDA 510(k) held by Cepheid, substantially equivalent on Oct 30, 2026 after 65 days, with no recalls tied to it in FDA's recall database.
- Review time: 65 days
- Recalls: 0
The Xpert Hemorrhagic Fever Panel, performed on the GeneXpert Dx system, is an automated multiplex real-time reverse transcription polymerase chain reaction (RT-PCR) test intended for the qualitative in vitro detection and identification of RNA from multiple biothreat agents: • Ebola virus (including Zaire, Sudan, Taï Forest, and Bundibugyo, not differentiated) • Crimean-Congo hemorrhagic fever…
- Xpert Hemorrhagic FeverK253653 · Cepheid · Feb 20, 2026
- T2 Biothreat PanelK231336 · T2biosystems, Inc. · Sep 15, 2023
- BioFire Global Fever Special Pathogens Panel; BIOFIRE SHIELD Control Kit for the BioFire Global Fever Special Pathogens…K213362 · Biofire Defense, LLC · Mar 22, 2023
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Aug 26, 2026
- Review panel
- Immunology
- Regulation
- 21 CFR 866.4000
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files